While statins offer benefits for lipid profiles, sexual function, and arterial stiffness in the general population, patients with familial hypercholesterolemia (FH) still face early cardiovascular disease […]
Androgens influence vascular remodeling. Pre-menopausal women show stable vascular biomarker measures (pulse pressure and augmentation index) across menstrual cycles, with lower stiffness than men from puberty […]
Atherosclerosis impacts all vascular beds, with the penile artery particularly susceptible due to its small diameter compared to larger central arteries. Kumagai et al. investigated whether […]
Men experience an age-related decline in sex hormones, termed “andropause,” linked to decreased bone density, muscle mass, and increased cardiovascular risk. Corrigan et al. investigated the […]
Untreated obstructive sleep apnea (OSA), especially when combined with obesity and male gender, increases all-cause and cardiovascular mortality. Androgen deficiency is common in both obese men […]
Male hypogonadism (low testosterone) is a recognized contributor to endothelial dysfunction and arterial stiffening, increasing cardiovascular mortality risk. Yaron et al. investigated the effects of testosterone […]
Androgen deprivation therapy (ADT) in prostate cancer induces hypogonadism with uncertain vascular effects. Smith et al. investigated ADT’s impact on vascular biomarkers in 22 patients, including […]